{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-000106","form_type":"8-K","ticker":"INDP","cik":"0001857044","company_name":"Indaptus Therapeutics, Inc.","filed_at":"2026-01-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.572589+00:00","generated_at":"2026-05-16T11:50:25.320695+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Three Indaptus Therapeutics directors resign pending stockholder vote on Lazar nominees","bullets":["Directors Michael Newman, Mark Gilbert, Anthony Maddaluna resigned effective upon approval of David Lazar's nominees at next stockholder meeting.","Resignations not due to any disagreement with Company, management, Board, or committees.","Board changes likely part of ongoing activist or settlement with David Lazar."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-000106","json":"https://secwatch.observer/filing/0001493152-26-000106.json","markdown":"https://secwatch.observer/filing/0001493152-26-000106.md","text":"https://secwatch.observer/filing/0001493152-26-000106.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1857044/000149315226000106/0001493152-26-000106-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1857044/000149315226000106/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T11:50:25.320695+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}